• Profile
Close

A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial

Dermatologic Therapy May 20, 2021

Spada F, Harrison IP, Barnes TM, et al. - Researchers conducted this randomized, double-blind, placebo-controlled, single centre, comparative trial to determine whether a two‐part system consisting of a ceramide‐dominant physiological lipid‐based moisturizing cream and cleanser could ameliorate the signs and symptoms of moderate eczema in adult patients compared with placebo over 28 days. Assessments were performed at baseline and every 7 days thereafter. There were no patients who dropped out of the study due to adverse events (AEs), and there were no serious AEs. Adults with eczema can benefit from a ceramide‐dominant moisturizing cream and cleanser that restores skin permeability and alleviates eczema symptoms.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay